FDA NDC Directory · JSON-LD · Markdown

Dexrazoxane

NDC 72205-247 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerNovadoz Pharmaceuticals LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA216748
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsDEXRAZOXANE HYDROCHLORIDE (250 mg/25mL)
Marketing started20250326
Package count1

External sources

Source: openFDA. Public-domain (CC0).